← The Wire
ZLABNasdaq
Zai Lab Ltd
Pharmaceutical Preparations · E9 · CIK 1704292
Zai Lab discovers, develops, and commercializes innovative therapies for oncology, immunology, neuroscience, and infectious disease
red 8-K · 90d
$1.92B
Market cap
$18.41
Last close
+2.3%
1D
-0.4%
5D
945K
Volume
Price · last 39 sessions-13.2%
May 4L $16.48 · H $21.22Jun 29
189
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
6-KFORM 6-KDec 29, 20206-KFORM 6-KDec 28, 20206-KFORM 6-KDec 1, 20206-K6-KOct 22, 20206-K6-KOct 9, 20206-K6-KSep 28, 20206-K6-KSep 22, 20206-K6-KSep 21, 20206-K6-KSep 16, 20206-KFORM 6-KSep 11, 20206-K6-KSep 11, 20206-K6-KSep 10, 20206-K6-KSep 4, 20206-K6-KAug 17, 20206-K6-KAug 13, 20206-KFORM 6-K FOR ZAI LAB LIMITED - AUGUST 7, 2020Aug 7, 20206-K6-KJul 20, 20206-K6-KJul 7, 20206-K6-KMay 13, 20206-K6-KApr 8, 20206-K6-KMar 19, 20206-K6-KMar 16, 20206-KFORM 6-KJan 27, 20206-KFORM 6-KJan 23, 20206-KFORM 6-KJan 22, 20206-K6-KJan 21, 20206-KFORM 6-KJan 21, 20206-K6-KJan 14, 20206-K6-KDec 27, 20196-K6-KSep 3, 20196-K6-KJul 2, 20196-K6-KJun 11, 20196-K6-KJun 3, 20196-KFORM 6-KMay 3, 20196-KFORM 6-KMay 2, 20196-KFORM 6-KMay 1, 20196-KFORM 6-KMay 1, 20196-K6-KMar 7, 20196-K6-KDec 12, 20186-K6-KNov 30, 20186-K6-KOct 22, 20186-K6-KOct 12, 20186-K6-KSep 27, 20186-K6-KSep 12, 20186-K6-KSep 6, 20186-K6-KSep 4, 20186-K6-KAug 30, 20186-K6-KAug 14, 20186-K6-KJun 5, 20186-K6-KMay 2, 20186-K6-KApr 25, 20186-KFORM 6-KApr 24, 20186-KFORM 6-KMar 5, 20186-KFORM 6-KJan 8, 20186-K6-KDec 19, 2017
Insider Activity
In the 90 days to Mar 17, 2026: 1 insider bought $33K · 5 sold $4.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Gaynor RichardDirector | Buy | 1,731 | $18.91 | $33K |
| Mar 13, 2026 | Amado RafaelSee Remarks | Sell | 2,957 | $18.63 | $55K |
| Mar 13, 2026 | Smiley Joshua LSee Remarks | Sell | 1,966 | $18.63 | $37K |
| Mar 13, 2026 | Chen YajingChief Financial Officer | Sell | 1,703 | $18.63 | $32K |
| Mar 13, 2026 | Edmondson Frazor Titus IiiChief Legal Officer | Sell | 1,281 | $18.63 | $24K |
| Mar 11, 2026 | Du YingChairperson & CEO | Sell | 1,067 | $19.08 | $20K |
| Mar 9, 2026 | Du YingChairperson & CEO | Sell | 50,000 | $19.03 | $952K |
| Mar 6, 2026 | Du YingChairperson & CEO | Sell | 50,000 | $19.42 | $971K |
| Mar 5, 2026 | Du YingChairperson & CEO | Sell | 50,000 | $19.22 | $961K |
| Mar 5, 2026 | Edmondson Frazor Titus IiiChief Legal Officer | Sell | 15,569 | $19.06 | $297K |
| Mar 4, 2026 | Du YingChairperson & CEO | Sell | 35,710 | $19.32 | $690K |
| Mar 4, 2026 | Du YingChairperson & CEO | Sell | 14,290 | $18.78 | $268K |
| Mar 3, 2026 | Amado RafaelSee Remarks | Sell | 10,000 | $17.38 | $174K |
| Dec 31, 2025 | Amado RafaelSee Remarks | Sell | 10,787 | $17.43 | $188K |
| Dec 16, 2025 | Edmondson Frazor Titus IiiChief Legal Officer | Sell | 8,651 | $17.14 | $148K |
| Nov 21, 2025 | Edmondson Frazor Titus IiiChief Legal Officer | Sell | 14,328 | $19.78 | $283K |
| Nov 3, 2025 | Chen YajingChief Financial Officer | Sell | 240 | $26.83 | $6K |
| Oct 2, 2025 | Chen YajingChief Financial Officer | Sell | 456 | $34.25 | $16K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance